Characterisation of Class 1 Integron among Escherichia coli Isolated from Mansoura University Hospitals in Egypt


Extensive use of antibacterials in clinical practice has been associated with increasing frequency of multi-resistant E. coli strains. Genetic elements such as Class 1 integrons have an important role in resistance development. In the current study, a total of 84 E. coli clinical isolates from Mansoura hospitals patients in Egypt were screened for antibacterial susceptibility against 12 different antibacterials. High resistance rates were identified for Ampicillin (92.9%) and sulfamethoxazole/ trimethoprim (84.5%). Class 1 integron was investigated in E. coli isolates by PCR. As a result, Class 1 integron was identified in 51.2% of these isolates. The contents of amplified integron varriable regions, were digested by Alu I restriction endonuclease. Cluster analysis of Class 1 integron digested varriable regions revealed that RFLP digested fragments generated could be classified into 9 different patterns, namely A, B, C, D, E, F, G, H and I. The most prevalent genotype was identifed in Group D. PCR and sequencing were used for detection of antimicrobial resistance genes harbored in integrons of Group D. As a result, main phylogenetic group identified harbored integron cassette carrying resistance gene for two antimicrobial groups namely aminoglycoside and trimethoprim. Multiresistance profiles in Group D exhibited association between antimicrobial resistance and integron presence. These findings suggest that the strategy for treatment of patients with E. coli infections needs to be revised. Furthermore, the high prevalence of Class 1 integron carrying gene confirms the importance of integron-mediated antimicrobial gene cassettes.

Share and Cite:

Adel El-Sokkary, M. and Abdelmegeed, E. (2015) Characterisation of Class 1 Integron among Escherichia coli Isolated from Mansoura University Hospitals in Egypt. Advances in Microbiology, 5, 269-277. doi: 10.4236/aim.2015.54025.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Yang, H., et al. (2004) Characterization of Multiple-Antimicrobial-Resistant Escherichia coli Isolates from Diseased Chickens and Swine in China. Journal of Clinical Microbiology, 42, 3483-3489.
[2] Barlow, R.S., et al. (2004) Isolation and Characterization of Integron-Containing Bacteria without Antibiotic Selection. Antimicrob Agents Chemother, 48, 838-842.
[3] Zanetti, M.O., et al. (2013) Antimicrobial Resistance, Plasmids and Class 1 and 2 Integrons Occurring in Pseudomonas aeruginosa Isolated from Brazilian Aquatic Environments. Water Science and Technology, 67, 1144-1149.
[4] Lu, L., et al. (2010) Characterization of Antimicrobial Resistance and Integrons among Escherichia coli Isolated from Animal Farms in Eastern China. Acta Tropica, 113, 20-25.
[5] Olsson-Liljequist, B., et al. (1997) Antimicrobial Susceptibility Testing in Sweden. III. Methodology for Susceptibility Testing. Scandinavian Journal of Infectious Diseases. Supplementum, 105, 13-23.
[6] Fluit, A. and Schmitz, F. (1999) Class 1 Integrons, Gene Cassettes, Mobility, and Epidemiology. European Journal of Clinical Microbiology & Infectious Diseases, 18, 761-770.
[7] Lee, J.C., et al. (2001) The Prevalence of Trimethoprim-Resistance-Conferring Dihydrofolate Reductase Genes in Urinary Isolates of Escherichia coli in Korea. Journal of Antimicrobial Chemotherapy, 47, 599-604.
[8] Nijssen, S., et al. (2005) Unnoticed Spread of Integron-Carrying Enterobacteriaceae in Intensive Care Units. Clinical Infectious Diseases, 41, 1-9.
[9] Collis, C.M., et al. (2002) Integron-Encoded IntI Integrases Preferentially Recognize the Adjacent Cognate attI Site in Recombination with a 59-Be Site. Molecular Microbiology, 46, 1415-1427.
[10] Cambray, G., Guerout, A.M. and Mazel, D. (2010) Integrons. Annual Review of Genetics, 44, 141-166.
[11] Navia, M.M., Ruiz, J. and Vila, J. (2004) Molecular Characterization of the Integrons in S higella Strains Isolated from Patients with Traveler’s Diarrhea. Diagnostic Microbiology and Infectious Disease, 48, 175-179.
[12] Mathai, E., Grape, M. and Kronvall, G. (2004) Integrons and Multidrug Resistance among Escherichia coli Causing Community-Acquired Urinary Tract Infection in Southern India. APMIS, 112, 159-164.
[13] Rijavec, M., Erjavec, M.S., Avgustin, J.A., Reissbrodt, R., Fruth, A., Krizan-Hergouth, V. and Zgur-Bertok, D. (2006) High Prevalence of Multidrug Resistance and Random Distribution of Mobile Genetic Elements among Uropathogenic Escherichia coli (UPEC) of the Four Major Phylogenetic Groups. Current Microbiology, 53, 158-162.
[14] Yu, H.S., Lee, J.C., Kang, H.Y., Ro, D.W., Chung, J.Y., Jeong, Y.S., et al. (2003) Changes in Gene Cassettes of Class 1 Integrons among Escherichia coli Isolates from Urine Specimens Collected in Korea during the Last Two Decades. Journal of Clinical Microbiology, 41, 5429-5433.
[15] Rao, A.N., Barlow, M., Clark, L.A., Boring, J.R., Tenover, F.C. and McGowan, J.E. (2006) Class 1 Integrons in Resistant Escherichia coli and Klebsiella spp., US Hospitals. Emerging Infectious Diseases, 12, 1011-1014.
[16] Ibrahim, M.E., Magzoub, M.A., Bilal, N.E. and Hamid, M.E. (2013) Distribution of Class I Integrons and Their Effect on the Prevalence of Multi-Drug Resistant Escherichia coli Clinical Isolates from Sudan. Saudi Medical Journal, 34, 240-247.
[17] Roe, M.T., Vega, E. and Pillai, S.D. (2003) Antimicrobial Resistance Markers of Class 1 and Class 2 Integron-Bearing Escherichia coli from Irrigation Water and Sediments. Emerging Infectious Diseases, 9, 822-826.
[18] Crichton, P. (1996) Enterobacteriaceae: Escherichia, Klebsiella, Proteus and Other Genera. In: Collee, J.G., Fraser, A.G., Marmion, B.P. and Simmons, A., Eds., Mckie and Maccarney Practical Medical Microbiology, 14th Edition, Churchill Living-Stone, Ebionburgh.
[19] NCCLS (2004) National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria: Approved Standard M31-A2. NCCLS, Wayne.
[20] Roe, M.T., Vega, E. and Pillai, S.D. (2003) Antimicrobial Resistance Markers of Class 1 and Class 2 Integron-Bearing Escherichia coli from Irrigation Water and Sediments. Emerging Infectious Diseases, 9, 822-826.
[21] Ochman, H., Lawrence, J.G. and Groisman, E.A. (2000) Lateral Gene Transfer and the Nature of Bacterial Innovation. Nature, 405, 299-304.
[22] Hall, R.M. and Collis, C.M. (1998) Antibiotic Resistance in Gram-Negative Bacteria: The Role of Gene Cassettes and Integrons. Drug Resistance Updates, 1, 109-119.
[23] Japoni, A., Gudarzi, M., Farshad, S., Basiri, E., Ziyaeyan, M., Alborzi, A. and Rafaatpour, N. (2008) Assay for Integrons and Pattern of Antibiotic Resistance in Clinical Escherichia coli Strains by PCR-RFLP in Southern Iran. Japanese Journal of Infectious Diseases, 61, 85-88.
[24] Tariq, N., Jaffery, T., Ayub, R., Alam, A.Y., Javid, M.H. and Shafique, S. (2006) Frequency and Antimicrobial Susceptibility of Aerobic Bacterial Vaginal Isolates. Journal of the College of Physicians and Surgeons Pakistan, 16, 196-199.
[25] Gulsun, S., Oguzoglu, N., Inan, A. and Ceran, N. (2005) The Virulence Factors and Antibiotic Sensitivities of Escherichia coli Isolated from Recurrent Urinary Tract Infections. Saudi Medical Journal, 26, 1755-1758.
[26] Sahm, D.F., Thornsberry, C., Mayfield, D.C., Jones, M.E. and Karlowsky, J.A. (2001) Multidrug-Resistant Urinary Tract Isolates of Escherichia coli: Prevalence and Patient Demographics in the United States in 2000. Antimicrobial Agents and Chemotherapy, 45, 1402-1406.
[27] Mazel, D. (2006) Integrons: Agents of Bacterial Evolution. Nature Reviews Microbiology, 4, 608-620.
[28] Karczmarczyk, M., Walsh, C., Slowey, R., Leonard, N. and Fanning, S. (2011) Molecular Characterization of Multidrug-Resistant Escherichia coli Isolates from Irish Cattle Farms. Applied and Environmental Microbiology, 77, 7121-7127.
[29] Leverstein-Van Hall, M.A., Paauw, A., Box, A.T., Blok, H.E., Verhoef, J. and Fluit, A.C. (2002) Presence of Integron-Associated Resistance in the Community Is Widespread and Contributes to Multidrug Resistance in the Hospital. Journal of Clinical Microbiology, 40, 3038-3040.
[30] Gassama, A., Aidara-Kane, A., Chainier, D., Denis, F. and Ploy, M.C. (2004) Integron-Associated Antibiotic Resistance in Enteroaggregative and Enteroinvasive Escherichia coli. Microbial Drug Resistance, 10, 27-30.
[31] Su, J.Y., Shi, L., Yang, L.S., Xiao, Z.H., Li, X.H. and Yamasaki, S. (2006) Analysis of Integrons in Clinical Isolates of Escherichia coli in China during the Last Six Years. FEMS Microbiology Letters, 254, 75-80.
[32] Zhang, H.M., Shi, L., Li, L., Guo, S.Y., Zhang, X.M., Yamasaki, S., et al. (2004) Identification and Characterization of Class 1 Integron Resistance Gene Cassettes among Salmonella Strains Isolated from Healthy Humans in China. Microbiology and Immunology, 48, 639-645.
[33] Chang, L.L., Chang, T.M. and Chang, C.Y. (2007) Variable Gene Cassette Patterns of Class 1 Integron-Associated Drug-Resistant Escherichia coli in Taiwan. Kaohsiung Journal of Medical Sciences, 23, 273-280.
[34] Kang, H.Y., Jeong, Y.S., Oh, J.Y., Tae, S.H., Choi, C.H., Moon, D.C., et al. (2005) Characterization of Antimicrobial Resistance and Class 1 Integrons Found in Escherichia coli Isolates from Humans and Animals in Korea. Journal of Antimicrobial Chemotherapy, 55, 639-644.
[35] Lindstedt, B.A., Heir, E., Nygard, I. and Kapperud, G. (2003) Characterization of Class I Integrons in Clinical Strains of Salmonella enterica Subsp. enterica Serovars Typhimurium and Enteritidis from Norwegian Hospitals. Journal of Medical Microbiology, 52, 141-149.
[36] Nógrády, N., Gadó, I., Tóth, A. and Pászti, J. (2005) Antibiotic Resistance and Class 1 Integron Patterns of Non-Typhoidal Human Salmonella Serotypes Isolated in Hungary in 2002 and 2003. International Journal of Antimicrobial Agents, 26, 126-132.
[37] Petersen, A., Guardabassi, L., Dalsgaard, A. and Olsen, J.E. (2000) Class I Integrons Containing a dhfrI Trimethoprim Resistance Gene Cassette in Aquatic Acinetobacter spp. FEMS Microbiology Letters, 182, 73-76.
[38] O’Brien, T.F. (2002) Emergence, Spread, and Environmental Effect of Antimicrobial Resistance: How Use of an Antimicrobial Anywhere Can Increase Resistance to Any Antimicrobial Anywhere Else. Clinical Infectious Diseases, 34, S78-S84.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.